Concepedia
Statistics
Publications
22
Citations
3.6K
H-Index
20
Active since
1993
Affiliations
Exelixis (United States)(Current)
Carolina Veterinary Specialists
Vanderbilt University
University of East-West Medicine
Oregon Health & Science University
Alison Joly is an author at Exelixis (United States) specializing in medicine, cell biology, and pharmacology.
Top concepts
MedicineCell BiologyPharmacologyCell SignalingAngiogenesisPathologyImmunologyBiochemistryInflammationTumor Biology
Publications per year
1993–2013
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes, Jason Chen, Jenny Tan et al. · Molecular Cancer Therapeutics · 2011 · 1.3K citations · Full text
Angiogenesis, Novel Met, Medicine +13
CTGF Expression is Induced by TGF- β in Cardiac Fibroblasts and Cardiac Myocytes: a Potential Role in Heart Fibrosis
Michelle Chen, Andrew Lam, Judith A. Abraham et al. · Journal of Molecular and Cellular Cardiology · 2000 · 435 citations
Cardiac Muscle, Cardiomyopathy, Fibrosis +11
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Fawn Qian, Stefan Engst, Peiwen Yu et al. · Cancer Research · 2009 · 336 citations
Tumor Cell Growth, Novel Inhibitor, Vegf Receptor 2 +16
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation
Stephanie Meyer, N.Gail Kohler, Alison Joly · FEBS Letters · 1997 · 158 citations · Full text
Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion
Nikki Cheng, Anna Chytil, Yu Shyr et al. · Molecular Cancer Research · 2008 · 157 citations · Full text
1–5 of 22